CHARDONNAY SHINN

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant ALISO VIEJO, CA NPI 1467857078

General Payments — all program years on this page

$1,290.05

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 62
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $487.08 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $487.0819

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $146.476
ABBVIE INC. $141.485
Lilly USA, LLC $91.493
Novo Nordisk AS $51.083
Hologic Sales and Service, LLC $29.751
GlaxoSmithKline, LLC. $26.811

By program year

Program yearAmountRecords
2021 $200.8113
2022 $433.0321
2023 $169.139
2024 $487.0819

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1084886201 Hologic Sales and Service, LLC $29.75 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100272552 Novo Nordisk Inc $16.82 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100330882 Novo Nordisk Inc $18.05 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100451744 Novo Nordisk Inc $16.21 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104579166 AstraZeneca Pharmaceuticals LP $14.64 03/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104773210 AstraZeneca Pharmaceuticals LP $16.25 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105449598 AstraZeneca Pharmaceuticals LP $25.14 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105463307 AstraZeneca Pharmaceuticals LP $34.71 05/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105706262 AstraZeneca Pharmaceuticals LP $29.87 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105896618 AstraZeneca Pharmaceuticals LP $25.86 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108190022 ABBVIE INC. $33.72 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108190024 ABBVIE INC. $11.26 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108190026 ABBVIE INC. $32.38 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108190028 ABBVIE INC. $30.14 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108190030 ABBVIE INC. $33.98 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116529220 GlaxoSmithKline, LLC. $26.81 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135582554 Lilly USA, LLC $30.33 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135589597 Lilly USA, LLC $27.34 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135594728 Lilly USA, LLC $33.82 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.